IA
IMCR icon

IFP Advisors’s Immunocore IMCR Stock Holding History

IFP Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.3K Hold
2,749
– – ﹤0.01% 2066
2026
Q1 		$82.9K Hold
2,749
– – ﹤0.01% 1966
2025
Q4 		$95.4K Sell
2,749
-27
-1% -$953 ﹤0.01% 1825
2025
Q3 		$101K Sell
2,776
-6
-0.2% -$204 ﹤0.01% 1673
2025
Q2 		$87.3K Sell
2,782
-16
-0.6% -$497 ﹤0.01% 1712
2025
Q1 		$83K Sell
2,798
-136
-5% -$4.08K ﹤0.01% 1633
2024
Q4 		$86.6K Buy
2,934
+96
+3% +$3.04K ﹤0.01% 1543
2024
Q3 		$88.3K Sell
2,838
-197
-6% -$7.17K ﹤0.01% 1463
2024
Q2 		$103K Sell
3,035
-27
-0.9% -$1.38K ﹤0.01% 1357
2024
Q1 		$199K Sell
3,062
-17
-0.6% -$1.17K 0.01% 1003
2023
Q4 		$210K Buy
3,079
+682
+28% +$35.4K 0.01% 926
2023
Q3 		$124K Buy
2,397
+594
+33% +$35.2K 0.01% 1161
2023
Q2 		$108K Buy
1,803
+1,703
+1,703% +$97.2K ﹤0.01% 1283
2023
Q1 		$4.32K Hold
100
– – ﹤0.01% 2628
2022
Q4 		$4K Buy
+100
New +$5.63K ﹤0.01% 3901

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

IFP Advisors's IMCR Position: Q2 2026 in Review

IFP Advisors held its Immunocore (IMCR) position steady in Q2 2026 at 2,749 shares worth $87.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

IFP Advisors first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. The position peaked at $210K in Q4 2023. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • IFP Advisors held 2,749 shares of Immunocore worth $87.3K as of Q2 2026.
  • IFP Advisors left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2066 holding.
  • IFP Advisors first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
  • IFP Advisors's Immunocore position peaked at $210K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.